Description: Moderna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday.
Date: Oct 12, 2022
Questions for discussion:
- Do you think think this collaboration is the right decision for both companies?
- What do you think about the bump in stock price?
- Would you be a buyer of these companies or other pharmaceuticals at this time?